Explore new clinical application of Huanglian and corresponding compound prescriptions from their traditional use

Zhongguo Zhongyao Zazhi

Volumn 33, Issue 10, 2008, Pages 1221-1225

  Feng, Yi Bin ^a   Luo, Wei Quan ^b   Zhu, Shi Qing ^c  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Stanley Ho Center for Emerging Infectious Diseases   (Hong Kong)

Author keywords

Compound prescriptions contain coptis; Coptis (Huanglian); Modern application; Traditional use

Indexed keywords

HERBACEOUS AGENT; HUANGLIAN;

ADULT; ARTICLE; CASE REPORT; CHINA; CHINESE MEDICINE; DIGESTIVE SYSTEM DISEASE; FEMALE; HISTORY; HUMAN; LIVER DISEASE; MALE; MIDDLE AGED; PRESCRIPTION;

ADULT; CHINA; DIGESTIVE SYSTEM DISEASES; DRUG PRESCRIPTIONS; DRUGS, CHINESE HERBAL; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HUMANS; LIVER DISEASES; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED;

EID: 44949194717     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Chinese source
2. Chinese source
3. Chinese source
4. Chinese source
5. Chinese source
6. Chinese source
7. Chinese source
8. Chinese source
9. Chinese source
10. Chinese source
11. Chinese source
12. Ohta Y, Sasaki E, Nishida K, et al. Inhibitory effect of Oren-gedoku-tu (Huanglian-Jie-Du-Tang) extract on hepatic triglyceride accumulation with the progression of carbon tetrachloride-induced acute liver injury in rats[J]. J Ethnopharmacol, 1998,6:75.
13. Romero M R, Efferth T, Serrano M A, et al. Effect of artemisinin/ artesunate as inhibitors of hepatitis B virus production in an in vitro replicative system[J]. Antiviral Res, 2005,68:75.
14. Anis K V, Rajeshkumar N V, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice[J]. J Pharm Pharmacol, 2001,53(5):763.
15. Chinese source
16. Jahnke G D, Price C J, Marr M C, et al. Developmental toxicity evaluation of berberine in rats and mice[J]. Birth Defects Res B Dev Reprod Toxicol, 2006,77(3):195.
17. Janbaz K H, Gilani A H. Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents [J]. Fitoterapia, 2000,71:25.
18. Hwang J M, Wang C J, Chou F P, et al. Inhibitory effect of berberine on tert-butyl hydroperoxide induced oxidative damage in rat liver[J]. Arch Toxicol, 2002,76:664.
19. Zhang B J, Xu D, Guo Y, et al. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors [J]. Clin Exp Pharmacol Physiol, 2007, 10:31.
20. Chinese source
21. Chinese source
22. Chinese source
23. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J]. Nat Med, 2004,10(12):1344.
24. Brusq J M, Ancellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine [J]. J Lipid Res, 2006,47(6):1281.
25. Luo W Q, Hui S C, Chan T Y, et al. Inhibitory effect of water extract from golden thread on leukemia L-1210 cells cultured in vitro[J]. Pharmacologist, 2002,44(2):193.
26. Kuo C L, Chi C W, Liu T Y. The anti-inflammatory potential of berberine in vitro and in vivo[J]. J Cancer Lett, 2004,203(2):127.
27. Chinese source
28. Chinese source